Affimed (Nasdaq: AFMD) engineers targeted immunotherapies, seeking to cure patients by harnessing the power of innate and adaptive immunity (NK and T cells). We are developing single and combination therapies to treat cancers and other life-threatening diseases.
To strengthen our highly motivated team in Heidelberg, Germany, we are looking for a
(Reference No. R05)
to support all preclinical development of novel biologics in immuno-oncology.
The successful candidate will have the unique opportunity to work in a dynamic, highly motivated, multidisciplinary and collegial team.